All GLP-1 receptor agonist articles
-
Industry newsEMA recommends marketing authorisation extension for Wegovy tablets
The European Medicines Agency (EMA) has endorsed an extension to the marketing authorisation of Wegovy (semaglutide) in the EU for weight management. The extension enables the use of tablets, making them the first glucagon-like peptide (GLP-1) receptor agonist for weight management developed for oral use.